Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000545275 | SCV000629341 | benign | Retinoblastoma | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001025836 | SCV001188100 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-06-02 | criteria provided, single submitter | clinical testing | The p.P232S variant (also known as c.694C>T), located in coding exon 7 of the RB1 gene, results from a C to T substitution at nucleotide position 694. The proline at codon 232 is replaced by serine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003470734 | SCV004208518 | uncertain significance | Malignant tumor of urinary bladder | 2023-08-21 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000545275 | SCV004844622 | uncertain significance | Retinoblastoma | 2024-02-05 | criteria provided, single submitter | clinical testing | This missense variant replaces proline with serine at codon 232 of the RB1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with unilateral retinoblastoma (RB1-LOVD database: RB1_000978). This variant has been identified in 1/31338 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Gene |
RCV004721416 | SCV005328183 | uncertain significance | not provided | 2023-10-13 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 23516486) |